CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
Form 483 Library → Visionary Medical Supplies Inc. → 483-3004161528-20260225
Form FDA 483 · Issued 2026-02-25

Visionary Medical Supplies Inc. — FDA Form 483 Analysis

FEI: 3004161528 · Sector: Pharmaceuticals & Sterile/OTC Drugs (Manufacturer) · Lead Investigator: Priya N. Subramanian

FDA Form 483 issued to Visionary Medical Supplies Inc. (FEI 3004161528) on 2026-02-25 following an inspection of its manufacturer operations in Wisconsin. The report documents 2 inspection observations centered on Finished Product Testing, Stability & Expiration Dating, Electronic Record Data Integrity (21 CFR Part 11) & Retention.

Get Full Annotated 483 Dossier + CAPA Checklist
Instant PDF + CFR Matrix ($79 vs. Redica's $289)
Buy Dossier ($79)
Need Help Fixing These 2 Citations?
Get matched with a vetted 21 CFR remediation consultant
Request Consultant

Observation-by-Observation 21 CFR Breakdown (2)

Observation #1 · 21 CFR 211.194(a)(1) Finished Product Testing, Stability & Expiration Dating
FIRST-TIME OBSERVATION
Sample identification and other information
Inspector Observation Language: "Laboratory records do not include [a description of the sample received for testing] [the source or location from where the sample was obtained] [the quantity of the sample] [the lot number or other distinctive code of the sample] [the date the sample was taken] [the date the sample was received for testing]. Specifically, observed during inspection of Visionary Medical Supplies Inc. on 2026-02-25."
Plain-English Meaning: Releasing finished batches without verifying strength/potency/microbiological specs, or placing an expiration/best-by date on labels without supporting real-time or accelerated stability data.
Standard CAPA Remediation Path: Require finished-batch microbiological (USP <2021>/<2022>), heavy metal, and active-assay release testing plus ICH stability chamber protocols supporting every label shelf-life claim.
Observation #2 · FDCA 501(a)(2)(A) Electronic Record Data Integrity (21 CFR Part 11) & Retention
REPEAT CITATION AT FACILITY
Exposed to lower quality air/ISO 5
Inspector Observation Language: "[Sterile drugs] [Materials] were exposed to lower than ISO 5 quality air. Specifically, observed during inspection of Visionary Medical Supplies Inc. on 2026-02-25."
Plain-English Meaning: Uncontrolled spreadsheets, shared laboratory logins, missing audit trails, backdated entries, or failure to retain batch and distribution records for the statutory window.
Standard CAPA Remediation Path: Enforce unique user credentials, immutable audit trails on analytical instruments, controlled form issuance numbers, and 2-year post-expiration record retention.